Sangamo BioSciences | SGMO - Чистый доход





Чистый доход Изменить Дата
Alaunos Therapeutics USD -1.01M 153K 2026-03
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Alterity Therapeutics Limited AUD -6.3M 525.41K 2025-12
Amgen USD 2.38B 556M 2026-06
Bayer EUR 219M 2.54B 2026-06
BioCryst Pharmaceuticals USD 78.4M 167.45M 2026-06
Biogen USD 97.5M 222M 2026-06
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Cipla INR 7.89B 2.34B 2026-06
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD -7.67M 64.51M 2026-03
CSL USD 401M 96.5M 2025-12
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
Grifols EUR 114.37M 34.03M 2025-12
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
J&J USD 5.53B 299M 2026-06
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
Merck USD -1.34B 2.9B 2026-06
Novartis USD 3.26B 108M 2026-06
Omeros USD -32.23M 23.81M 2024-09
Pfizer USD -248M 2.94B 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR 343M 1.27B 2026-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Tectonic Therapeutic USD -25.24M 6.02M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06